HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
Home » News » Carbon Bioscience Partners with the Cystic Fibrosis Foundation to Develop New Viral Vector-Based Therapy

Carbon Bioscience Partners with the Cystic Fibrosis Foundation to Develop New Viral Vector-Based Therapy

Although adeno-associated virus (AAV) gene therapies have represented a large swath of the gene therapeutic landscape for years, they have been weighed down by various limitations and adverse effects. The biotech Carbon Biosciences, led by seeks to disrupt the field of cystic fibrosis gene therapies by introducing new viral vector to the mix, bocavirus. This move is made as part of a new $38 million partnership with the Cystic Fibrosis Foundation.

According to Kyle LaHucik, “The startup’s first therapy, named CGT-001, can be delivered more than once, specifically targets the lung tissue and is able to transport the full-length cystic fibrosis gene, Schneider tells Endpoints News. The lead candidate is also able to carry 30% to 40% more than the typical AAV, which Schneider knows a thing or two about after eight years in the C-suite at AAV-based Solid Biosciences, which is attempting to tackle Duchenne muscular dystrophy.”

To learn more, click here.

(Source: Endpoints News, June 21st, 2022)

You might be interested in:

  1. Abbvie Scraps Cystic Fibrosis Triplet Therapy
  2. [Webinar] Patient-Focused Medicines Development During COVID-19
  3. 2021 CDER Report: New Approvals Improve Patient Treatment Options
  4. China Announces Price Cuts, Hitting Astrazeneca, Pfizer, and Novartis’s Profits

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • RWD Scientist - Oncology
  • Senior/Executive Director, Evidence Synthesis
  • Associate Director / Director, Market Access
  • Scientist, Real World Evidence (RWE) Analytics
  • Senior/Executive Director, Modeling
 
Syndicated Reports

Current and Future Analysis of Real World Data Market With New Business Strategies and Forecast by 2029 Parexel International Corporation, TriNetX LLC

Global Gene Therapy Report 2022-2031

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Economic & Related Consulting Service Revenues World Report & Database

 
White Papers

How Corporate Executives View Rising Health Care Cost and the Role of Government

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Build or Buy – Which Is the Right QMS Choice for Your Company?

Finland – A treasure trove for real-world evidence (RWE) research and innovation

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists